[1] Livermore, D. (2012) Current Epidemiology and Growing Resistance of Gram-Negative Pathogens. Korean Journal of Internal Medicine, 27, 128-142. http://dx.doi.org/10.3904/kjim.2012.27.2.128
[2] Lowe, F.C., Mcgeer, A., Muller, M.P. and Katz, K. (2012) For the Toronto ESBL Working Group. Decreased Susceptibility to Noncarbapenem Antimicrobials in Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Toronto, Canada. Antimicrobial Agents and Chemotherapy, 56, 3977-3980. http://dx.doi.org/10.1128/AAC.00260-12
[3] Yigit, H., Queenan, A.M., Anderson, G.J., Domenech-Sanchez, A., Biddle, J.W., Steward, C.D., et al. (2001) Novel Carbapenem-Hydrolyzing β-Lactamase KPC-1 from a Carbapenem-Resistant Strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 45, 1151-1161. http://dx.doi.org/10.1128/AAC.45.4.1151-1161.2001
[4] Naas, T., Cuzon, G., Truong, H.V. and Nordmann, P. (2012) Role of ISKpn7 and Deletions in blaKPC Gene Expression. Antimicrobial Agents and Chemotherapy, 56, 4753-4759.
http://dx.doi.org/10.1128/AAC.00334-12
[5] Poirel, L., Naas, T. and Nordmann, P. (2010) Diversity, Epidemiology, and Genetics of Class D β-Lactamases. Antimicrobial Agents and Chemotherapy, 54, 24-38. http://dx.doi.org/10.1128/AAC.01512-08
[6] Sader, H.S., Jones, R.N., Gales, A.C., Silva, J.B. and Pignatari, A.C., Participantes do grupo Sentry (América Latina) (2004) SENTRY Antimicrobial Surveillance Program Report: Latinamerican and Brazilian Results for 1997 through 2001. Brazilian Journal of Infectious Diseases, 8, 25-79. http://dx.doi.org/10.1590/S1413-86702004000100004
[7] Rice, L.B. (2008) Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE. Journal of Infectious Diseases, 197, 1079-1081. http://dx.doi.org/10.1086/533452
[8] Clinical and Laboratory Standards Institute (CLSI) (2011) Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Tenth Edition. CLSI Document M02-A10. Clinical and Laboratory Standards Institute, Wayne.
[9] Nordmann, P., Poirel, L. and Dortet, L. (2012) Rapid Detection of Carbapenemase Producing Enterobacteriaceae, Emerging Infectious Diseases, 8,1503-1507.
http://dx.doi.org/10.3201/eid1809.120355
[10] Odeh, R., Kelkar, S., Hujer, A.M., Bonomo, R.A., Schreckenberger, P.C. and Quinn, J.P. (2002) Broad Resistance Due to Plasmid-Mediated AmpC b-Lactamases in Clinical Isolates of Escherichia coli. Clinical Infectious Diseases, 35, 140-145. http://dx.doi.org/10.1086/340742
[11] Girlich, D., Damaceno, Q.S., Oliveira, A.C. and Nordmann, P. (2014) OXA-253, a Variant of the Carbapenem-Hydrolyzing Class D β-Lactamase OXA-143 in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 58, 2976-2978. http://dx.doi.org/10.1128/AAC.02640-13
[12] Papadimitriou-Olivgeris, M., Marangos, M., Fligou, F., Christofidou, M., Bartzavali, C., Anastassiou, E.D., et al. (2012) Risk Factors for KPC-Producing Klebsiella pneumoniae Enteric Colonization upon ICU Admission. Journal of Antimicrobial Chemotherapy, 67, 2976-2981. http://dx.doi.org/10.1093/jac/dks316
[13] Feldman, N., Adler, A., Molshatzki, N., Navon-Venezia, S., Khabra, E., Cohen, D. and Carmeli, Y. (2013) Gastrointestinal Colonization by KPC-Producing Klebsiella pneumoniae Following Hospital Discharge: Duration of Carriage and Risk Factors for Persistent Carriage. Clinical Microbiology and Infection, 19, E190-E196. http://dx.doi.org/10.1111/1469-0691.12099
[14] Towner, K.J. (2009) Acinetobacter: An Old Friend, but a New Enemy. Journal of Hospital Infection, 73, 355-363. http://dx.doi.org/10.1016/j.jhin.2009.03.032
[15] Kempf, M. and Rolain, J.M. (2012) Emergence of Resistance to Carbapenems in Acinetobacter baumannii in Europe: Clinical Impact and Therapeutic Options. International Journal of Antimicrobial Agents, 39, 105-114. http://dx.doi.org/10.1016/j.ijantimicag.2011.10.004
[16] Paterson, D.L. (2008) The Molecular Epidemiology of Extended-Spectrum Beta-Lactamase Producing Organisms. Enfermedades Infecciosas y Microbiología Clínica, 26, 403.
http://dx.doi.org/10.1157/13125635
[17] Lartigue, M.F., Zinsius, C., Wenger, A., Bille, J., Poirel, L. and Nordmann, P. (2007) Extended-Spectrum β-Lactamases of the CTX-M Type Now in Switzerland. Antimicrobial Agents and Chemotherapy, 51, 2855-2860. http://dx.doi.org/10.1128/AAC.01614-06
[18] Ruppé, E., Pitsch, A., Tubach, F., Lastours, V., Chau, F., Pasquet, B., et al. (2012) Clinical Predictive Values of Extended-Spectrum Beta-Lactamase Carriage in Patients Admitted to Medical Wards. European Journal of Clinical Microbiology & Infectious Diseases, 31, 319-325. http://dx.doi.org/10.1007/s10096-011-1313-z
[19] Gionco, B., Pelayo, J.S., Venancio, E.J., Caio, R., Gales, A.C. and Carrara-Marroni, F.E. (2012) Detection of OXA-231, a New Variant of blaOXA-143, in Acinetobacter baumannii from Brazil: A Case Report. Journal of Antimicrobial Chemotherapy, 67, 2531-2532. http://dx.doi.org/10.1093/jac/dks223
[20] Zander, E., Bonnin, R.A., Seifert, H. and Higgins, P.G. (2014) Characterization of blaOXA-143 Variants in Acinetobacter baumannii and Acinetobacter pittii. Antimicrobial Agents and Chemotherapy, 58, 2704-2708. http://dx.doi.org/10.1128/AAC.02618-13
[21] Higgins, P.G., Poirel, L., Lehmann, M., Nordmann, P. and Seifert, H. (2009) OXA-143, a Novel Carbapenem-Hidrolyzing Class D β-Lactamase in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 53, 5035-5038. http://dx.doi.org/10.1128/AAC.00856-09
[22] Opazo, A., Domínguez, M., Bello, H., Amyes, S.G. and Rocha, G. (2012) OXA-Type Carbapenemases in Acinetobacter baumannii in South America. Journal of Infection in Developing Countries, 6, 311-316.
[23] Sostarich, A.M., Zolldann, D., Haefner, H., Luetticken, R., Schulze-Roebecke, R. and Lemmen, S.W. (2008) Impact of Multiresistance of Gram-Negative Bacteria in Bloodstream Infection on Mortality Rates and Length of Stay. Infection, 36, 31-35. http://dx.doi.org/10.1007/s15010-007-6316-4
[24] Willwmsen, I., Elberts, S., Verhulst, C., Rijnsburger, M., Filius, M., Savelkoul, P., et al. (2011) Highly Resistant Gram-Negative Microorganisms: Incidence Density and Occurrence of Nosocomial Transmission (TRIANGLE Study). Infection Control and Hospital Epidemiology, 32, 333-341. http://dx.doi.org/10.1086/658941
[25] Grice, E.A., Kong, H.H., Conlan, S., Deming, C.B., Davis, J., Young, A.C., et al. (2009) Topographical and Temporal Diversity of the Human Skin Microbiome. Science, 324, 1190-1192. http://dx.doi.org/10.1126/science.1171700
[26] Chen, Y.E. and Tsao, H. (2013) The Skin Microbiome: Current Perspectives and Future Challenges. Journal of the American Academy of Dermatology, 69, 143-155. http://dx.doi.org/10.1016/j.jaad.2013.01.016